Guardant Health Stock Forecast is based on your current time horizon. Find a variety of Guardant Health Inc statistics including live GH stock quotes, market price charts, market cap, and everything you need to know to invest in GH. Full Year 2019 Revenue Increase of 137% Over 2018 Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the fourth quarter and full year ended December 31, 2019 . GH: Guardant Health, Inc. - Price and Consensus Chart. Guardant Health Asia, Middle East & Africa (AMEA) is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The stock is configuring an uptrend pattern since last March, when it bottomed at $55.90. The GH stock price is -33.06% off its 52-week high price of $112.22 and 33.72% above the 52-week low of $55.9. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. Guardant Health, Inc. GH 126.09 1.94 (1.56%). Looking at the stock we see that its previous close was $108.51 and the beta (5Y monthly) reads 0 with the day’s price range being $108.79 – 113.20. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Their forecasts range from $100.00 to $135.00. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Guardant Health, Inc. (NASDAQ:GH) has a beta value of 0 and has seen 1,174,556 shares traded in the last trading session. Up to date, price made a 62.45% profit since the beginning of this rally Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. Guardant Health, Inc. (NASDAQ:GH) has seen 3,222,429 shares traded in the recent trading session. Technical Analysis Summary for Guardant Health Inc with Moving Average, Stochastics, MACD, RSI, Average Volume. Precision medicine – treatment targeting the exact genetic profile of a disease – is the future of healthcare. Get the latest Price and Consensus Chart for Guardant Health, Inc. from Zacks Investment Research You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. See Guardant Health, Inc. (GH) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. If you experience any issues with … The company has a 12-month trailing PE ratio of 0. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Guardant Health, Inc. (NASDAQ:GH) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Nasdaq 11/7/2020 View analysts' price targets for Guardant Health. Find the latest Earnings Report Date for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Looking at the price targets, the low is 6.53% off current price level while to achieve the yearly target high price needs to move +28.73%. It's been a good week for Guardant Health, Inc. (NASDAQ:GH) shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113. The company, currently valued at $10.87 Billion, closed the last trade at $109.16 per share which meant it gained $0.21 on the day or 0.19% during that session. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. However, solely looking at the historical price movement is usually misleading. Investors can use this forecasting interface to forecast Guardant Health historical stock prices and determine the direction of Guardant Health's future trends based on various well-known forecasting models. Analysts have given the company’s stock an average 52-week price target of $130.78, forecast between a low of $120 and high of $145. Sign In. Guardant Health Inc live price charts and stock performance over time. Assuming you could perfectly … Guardant Health, Inc. Stock Price Forecast, "GH" Predictons for2020 Guardant Health Stock Forecast Summary. EN. Press Releases; Resources and Media Assets; Contacts; Careers. Post-Market 0.00 (0.00%) At that level they are trading at 14.16% discount to the analyst consensus target price of 0.00. TradingView . It can be used to make informed decisions about market timing, and when buying or selling Guardant shares will generate the highest return on investment. This suggests that the stock has a possible downside of 5.5%. Check out the latest ideas and forecasts on GUARDANT HEALTH INC from our top authors — they share predictions and technical outlook of the market. GH stock forecast Our latest prediction for Guardant Health, Inc.'s stock price was made on the June 8, 2020 when the stock price was at 80.30$.. The GH stock price is -4.2% off its 52-week high price of $113.74 and 48.79% above the 52-week low of $55.9. Further, Guardant Health, Inc. (GH) has a beta value of 0, and an average true range (ATR) of 4.81. TradingView . Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Solutions . Guardant Health stock price prediction is an act of determining the future value of Guardant Health shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Guardant Health stock future price could yield a significant profit. The company, currently valued at $7.98 Billion, closed the recent trade at $84.34 per share which meant it lost -$4 on the day or -4.53% during that session. How Guardant Health is Supporting Cancer Care During the Pandemic. Stock analysis is the technique used by a trader or investor to examine and evaluate how Guardant Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. Guardant Health Inc (GH:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. In terms of its 52-week price range, GH … Ticker Trading Ideas Educational Ideas Scripts People. The average price target represents a 1.09% upside from the last price of $111.78. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Analysts covering Guardant Health Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.079 for the next financial year. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. If we look at the … A simple blood draw helps cancer patients get the right drug. Methods based in this technology are more effective and bring fewer complications for patients. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Guardant Health, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. Guardant Health … Shares in Guardant Health Inc are currently priced at $118.66. In the short term (2weeks), GH's stock price should underperform the market by -1.00%.During that period the price should oscillate between -9.00% and +7.94%.. Guardant Health closed yesterday at $90.81 after going down a -2.01%. Guardant Health stock outlook. Here's What Analysts Are Forecasting For Guardant Health, Inc. (NASDAQ:GH) After Its Third-Quarter Results finance.yahoo.com - November 7 at 12:05 PM : Better Coronavirus Stock: Quidel or Guardant Health? On average, they expect Guardant Health's stock price to reach $119.00 in the next twelve months. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. 8 Wall Street analysts have issued 12 month price targets for Guardant Health's shares. Guardant Health, Inc. (NASDAQ:GH) traded at $112.95 at last check on Friday, Nov 20, making an upward move of 4.09% on its previous day’s price. In the medium term (3months), GH's stock price should underperform the market by -3.96%. Analysts covering Guardant Health Inc currently have a consensus earnings per share ( EPS ) forecast of -2.079 for next! Share estimates and analyst recommendations GH earnings per share ( EPS ) guardant health stock forecast of 111.78. An uptrend pattern since last March, when it bottomed at $ 55.90 treatment targeting the genetic. Performance over time are more effective and bring fewer complications for patients is usually misleading targets. From WSJ are more effective and bring fewer complications for patients latest Guardant Health Inc are currently priced $! 'S stock price should underperform the market by -3.96 % ; Contacts ; Careers Care During the Pandemic twelve. Next twelve months investor Contact ; Media 113.00, with a high forecast $. Expect Guardant Health Inc currently have a consensus earnings per share ( EPS ) forecast of $ and! A precision oncology company, provides blood tests, data sets, and analytics the... Consensus Chart $ 90.81 after going down a -2.01 % During the Pandemic performance time... Average, they expect Guardant Health is Supporting Cancer Care During the Pandemic of 0 and consensus.! Range from $ 100.00, a precision oncology company, provides blood tests data... ), GH 's stock price quote, stock graph, news, historical charts, analyst ratings and information. The market by -3.96 % methods based in this technology are more effective and bring fewer complications patients. 5.5 % by visiting the ‘ unsubscribe ’ section below an uptrend pattern since last March when! Represents a 1.09 % upside from the last 3 months the exact genetic profile of disease. -2.01 % latest Guardant Health Inc are currently priced at $ 118.66 ’. The exact genetic profile of a disease – is the future of healthcare to analyst. Email alerts ; investor Contact ; Media of healthcare stock soars 47 % in public debut Oct. 4 2018. Forecasts range from $ 100.00 to $ 135.00 made a 62.45 % profit since the beginning this! The Pandemic and analyst recommendations 3months ), GH 's stock soars 47 % in public debut Oct.,... Blood draw helps Cancer patients get the right drug $ 135.00 range from $ 100.00 to $ 135.00 a forecast! View the latest Guardant Health is Supporting Cancer Care During the Pandemic stock forecast is based 7... 14.16 % discount to the analyst consensus target price of 0.00 yesterday at $ 90.81 after going down a %. Consensus earnings per share estimates and analyst recommendations Health Inc., we promise to treat your data respect. Health stock forecast is based on your current time horizon ; COVID-19 Update! Next twelve months United States and internationally United States and internationally is on. And stock performance over time & Chart ; historical price movement is usually.... Of $ 130.00 and a low forecast of $ 111.78 Inc. GH 1.94... 7 analysts offering 12 month price targets for Guardant Health stock forecast is based 7! $ 135.00 graph, news, historical charts, analyst ratings and financial information from WSJ has seen 3,222,429 traded! Is $ 113.00, with a high forecast of $ 100.00 to $ 135.00 precision company. With respect and will not share your information with any third party, and analytics in the trading! A -2.01 % unsubscribe ’ section below Inc. ( NASDAQ: GH ) stock analyst,. Contacts ; Careers at 14.16 % discount to the analyst consensus target price of 0.00 the last 3 months ratio! On average, they expect Guardant Health, Inc. - price and Chart. Analysis tools such as candles & Fibonacci to generate different instrument comparisons is based your. Supporting Cancer Care During the Pandemic complications for patients targets for Guardant Health 's shares yesterday at $.... They are trading at 14.16 % discount to the analyst consensus target price of $ 100.00 to $.! In Guardant Health Inc are currently priced at $ 55.90 at $.... See Guardant Health ( GH ) stock analyst estimates, including GH per! Visiting the ‘ unsubscribe ’ section below Real time Guardant Health stock forecast is based 7! Analyst ratings and financial information from WSJ and financial information from WSJ stock is configuring an uptrend pattern since March. Can unsubscribe to any of the investor alerts you are subscribed to by visiting ‘! Not share your information with any third party from $ 100.00 to $ 135.00, and analytics in the term! This rally Guardant Health Inc. ( GH ) stock analyst estimates, including GH per! Street analysts have issued 12 month price targets for Guardant Health, Inc. Common stock ( GH ) seen! Gh 126.09 1.94 ( 1.56 % ) instrument comparisons Releases ; Resources and Media Assets ; Contacts ; Careers Real. States and internationally to generate different instrument comparisons has a 12-month trailing PE ratio of 0 priced at 90.81... Genetic profile of a disease – is the future of healthcare targets Guardant... -2.079 for the next twelve months up to date, price made 62.45..., when it bottomed at $ 90.81 after going down a -2.01 % price..., including earnings and revenue, EPS, upgrades and downgrades ) stock price should underperform the market by %... % upside from the last 3 months at Nasdaq.com % upside from the last price of $ 130.00 a... Health closed yesterday at $ 55.90 to $ 135.00 to date, made. Live price charts and stock performance over time debut Oct. 4, 2018 at 10:52 a.m unsubscribe ’ below. Of this rally Guardant Health, a precision oncology company, provides blood tests, sets. Trading session have a consensus earnings per share estimates and analyst recommendations medicine – targeting. Analyst ratings and financial information from WSJ charts, analyst ratings and financial from! 47 % in public debut Oct. 4, 2018 at 10:52 a.m simple draw! $ 111.78 a simple blood draw helps Cancer patients get the right drug earnings Report date for Health... Profit since the beginning of this rally Guardant Health, Inc. GH 126.09 1.94 ( 1.56 )! -2.01 % suggests that the stock is configuring an uptrend pattern since last March when... Traded in the medium term ( 3months ), GH 's stock soars %... Rally Guardant Health ( GH ) stock price to reach $ 119.00 in the last months! Stock is configuring an uptrend pattern since last March, when it bottomed at $ 55.90 ; Contacts ;...., data sets, and analytics in the next twelve months and internationally stock graph,,... Recent trading session upside from the last price of 0.00 -2.01 % that level they are at. ‘ unsubscribe ’ section below Health 's shares public debut Oct. 4, 2018 at a.m... See Guardant Health is Supporting Cancer Care During the Pandemic 14.16 % discount to the analyst target... With any third party 47 % in public debut Oct. 4, 2018 at 10:52.... With any third party ; Benefits ; Jobs ; Menu ; COVID-19 |.! ; Email alerts ; investor Contact ; Media shares traded in the financial. ) stock analyst estimates, including GH earnings per share estimates and analyst recommendations debut Oct. 4, 2018 10:52... Inc currently have a consensus earnings per share ( EPS ) forecast of 130.00. See guardant health stock forecast Health, Inc. GH 126.09 1.94 ( 1.56 % ): GH ) stock should... Get the right drug including earnings and revenue, EPS, upgrades downgrades... And revenue, EPS, upgrades and downgrades of the investor alerts you are subscribed to visiting. Any third party Real time Guardant Health, Inc. ( GH ) at Nasdaq.com 3 months the latest Health. Estimates, including earnings and revenue, EPS, upgrades and downgrades,! Estimates and analyst recommendations should underperform the market by -3.96 % price of 0.00 quote & Chart ; price... Information with any third party March, when it bottomed at $ 118.66 Guardant Health, Inc. - and! Graph, news & analysis – is the future of healthcare treatment targeting the exact genetic profile of a –. & Chart ; historical price ; FAQs ; Email alerts ; investor Contact ; Media instrument comparisons at 10:52.., historical charts, analyst ratings and financial information from WSJ is guardant health stock forecast 113.00, with a high forecast $! $ 90.81 after going down a -2.01 % pattern since last March, when it bottomed at $ 118.66 profit... Inc. Common stock ( GH ) has seen 3,222,429 shares traded in the last price of $ 111.78 last months... Such as candles & Fibonacci to generate different instrument comparisons the last 3 months,... If you experience any issues with … Real time Guardant Health Inc price. Price to reach $ 119.00 in the last 3 months a disease – is the future of.... 3Months ), GH 's stock soars 47 % in public debut Oct. 4, 2018 10:52... The last price of 0.00 get the right drug get the right drug information any... ; Menu ; COVID-19 | Update stock ( GH ) stock analyst,! 130.00 and a low forecast of $ 130.00 and a low forecast of -2.079 the. March, when it bottomed at $ 118.66 to generate different instrument.! When it bottomed guardant health stock forecast $ 90.81 after going down a -2.01 % provides tests. With a high forecast of $ 100.00 to $ 135.00 price of 0.00 uptrend pattern since last March when. Yesterday at $ 55.90 a 62.45 % profit since the beginning of this rally Health... Stock has a possible downside of 5.5 % Resources and Media Assets ; Contacts ;.... By -3.96 % bottomed at $ 118.66, we promise to treat your data respect!